Tumour necrosis factor in mouse models of chronic intestinal inflammation

Immunology

Volumn 105, Issue 1, 2002, Pages 1-8

  Mueller, Christoph ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b S   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INFLIXIMAB; INTERLEUKIN 6; MESSENGER RNA; PHOSPHOLIPASE A2; TUMOR NECROSIS FACTOR;

CROHN DISEASE; DISEASE COURSE; DISEASE MODEL; ENTERITIS; HUMAN; IMMUNOPATHOLOGY; IMMUNOREGULATION; INTESTINE MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ULCERATIVE COLITIS;

ANIMALS; ANTIBODIES, MONOCLONAL; IN SITU HYBRIDIZATION; INFLAMMATORY BOWEL DISEASES; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASES; MICE; MICE, KNOCKOUT; MICE, SCID; MICE, TRANSGENIC; MODELS, ANIMAL; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0036161995     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2002.01329.x     Document Type: Review

References (63)

1. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion
2. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages
3. The pathophysiology of tumor necrosis factors
4. Tumor necrosis factor: Biology and therapeutic inhibitors
5. Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN
6. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation
7. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin
8. Signaling by the TNF receptor superfamily and T cell homeostasis
9. Signal transduction by tumor necrosis factor: The Parker B. Francis lectureship
10. Inflammatory bowel disease: Etiology and pathogenesis
11. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting
12. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
13. Typhlocolitis in NF-kappa B-deficient mice
14. Experimental models of inflammatory bowel disease
15. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-Cadherin
16. + T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice
17. + T cells
18. + T cells
19. Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG) 2 (-/-) mice upon transfer of CD4 (+) CD45RB (hi) T cells
20. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25 (+) CD4 (+) regulatory cells that control intestinal inflammation
21. Control of immune pathology by regulatory T cells
22. Control of experimental inflammatory bowel disease by regulatory T cells
23. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease
24. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
25. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
26. Infliximab for the treatment of fistulas in patients with Crohn's disease
27. + T cells
28. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis
29. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
30. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies
31. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
32. Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNFalpha) mediates effects distinct from those of wild-type TNFalpha in vitro and in vivo
33. TNF-induced enterocyte apoptosis and detachment in mice: Induction of caspases and prevention by a caspase inhibitor, ZVAD-fmk
34. TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53
35. Small bowel enteropathy: Role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-gamma, TNF) in the induction of epithelial cell death and renewal
36. T-cell activation can induce either mucosal destruction or adaptation in cultured human fetal small intestine
37. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers
38. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations
39. Modulating dendritic cells to optimize mucosal immunization protocols
40. Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence
41. Uptake and presentation of antigen to T cells by primary colonic epithelial cells in normal and diseased states
42. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells
43. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation
44. Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease
45. Expression of the neutrophil chemokine KC in the colon of mice with enterocolitis and by intestinal epithelial cell lines: Effects of flora and proinflammatory cytokines
46. Regulation of autoimmunity by proinflammatory cytokines
47. TNF neutralization in MS: Results of a randomized, placebo-controlled mulricenter study
48. Role of cytokines in the early stages of chronic colitis in TCR alpha-mutant mice
49. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice
50. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death
51. Interleukin-10-deficient mice develop chronic enterocolitis
52. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice
53. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T-cell responsiveness to TGF-beta
54. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells
55. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa
56. + T cells that respond to bacterial antigens
57. Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice
58. + transgenic T cells in spontaneous inflammatory bowel disease in lymphopenic mice
59. Severe colitis in mice with aberrant thymic selection
60. Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice
61. A novel model of inflammatory bowel disease: Mice deficient for the multiple drug resistance gene, mdrla, spontaneously develop colitis
62. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor
63. Fulminant jejunoileitis following ablation of enteric glia in adult transgenic mice